October 25, 2018
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Re: | Moleculin Biotech, Inc. |
Registration Statement on Form S-1
Registration No. 333-227845
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Moleculin Biotech, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 P.M. (Eastern Time) on October 26, 2018, or as soon thereafter as possible on such date.
Very truly yours, | |||
Moleculin Biotech, Inc. | |||
By: | /s/ Jonathan Foster | ||
Name: Jonathan Foster | |||
Title: Chief Financial Officer |